Tenax Therapeutics Inc (TENX)

Currency in USD
5.9900
+0.0600(+1.01%)
Closed·
5.8700-0.1200(-2.00%)
·
TENX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
TENX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.91506.0200
52 wk Range
3.25007.8900
Key Statistics
Prev. Close
5.93
Open
5.9594
Day's Range
5.915-6.02
52 wk Range
3.25-7.89
Volume
10.06K
Average Volume (3m)
26.84K
1-Year Change
50.13%
Book Value / Share
2.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TENX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.5000
Upside
+208.85%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Tenax Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Tenax Therapeutics Inc Company Profile

Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Compare TENX to Peers and Sector

Metrics to compare
TENX
Peers
Sector
Relationship
P/E Ratio
−7.6x−2.9x−0.5x
PEG Ratio
−0.080.020.00
Price/Book
2.3x1.5x2.6x
Price / LTM Sales
-132.5x3.2x
Upside (Analyst Target)
183.8%176.2%38.8%
Fair Value Upside
Unlock10.7%5.4%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.5000
(+208.85% Upside)

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-0.27 / -0.21
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TENX Income Statement

People Also Watch

18.20
SRPT
-0.76%
1.540
ALLR
+2.67%
1.130
TNYA
0.00%
0.095
WINT
-1.04%
1.130
ALLO
-4.24%

FAQ

What Stock Exchange Does Tenax Therapeutics Trade On?

Tenax Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tenax Therapeutics?

The stock symbol for Tenax Therapeutics is "TENX."

What Is the Tenax Therapeutics Market Cap?

As of today, Tenax Therapeutics market cap is 239.54M.

What Is Tenax Therapeutics's Earnings Per Share (TTM)?

The Tenax Therapeutics EPS (TTM) is -0.94.

From a Technical Analysis Perspective, Is TENX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Tenax Therapeutics Stock Split?

Tenax Therapeutics has split 5 times.

How Many Employees Does Tenax Therapeutics Have?

Tenax Therapeutics has 5 employees.

What is the current trading status of Tenax Therapeutics (TENX)?

As of 31 Aug 2025, Tenax Therapeutics (TENX) is trading at a price of 5.9900, with a previous close of 5.93. The stock has fluctuated within a day range of 5.9150 to 6.0200, while its 52-week range spans from 3.2500 to 7.8900.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.